Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin B pseudogene 5 (UBBP5) is a human pseudogene closely related to the functional UBB gene, which encodes ubiquitin, a highly conserved protein central to protein degradation and cell regulation[7][1][8]. UBBP5 and related pseudogenes are considered nonfunctional, as they do not encode active ubiquitin protein due to sequence disruptions, and there is no current evidence they play a direct role in biological processes. No drugs, diagnostic markers, or therapeutic strategies target UBBP5. Pseudogenes like UBBP5 are sometimes transcribed but generally do not produce functional protein due to disruptive mutations[8][1]. Functional ubiquitin is encoded by genes such as UBB, UBC, RPS27A, and UBA52, not by their pseudogene counterparts[1][4][6]. Although some pseudogenes have been found to contribute to regulatory RNA, there is no evidence that UBBP5 has such a function[1][8]. In summary: Ubiquitin B pseudogene 5 (UBBP5) is not a protein, receptor, or a drug target. It is best classified as a pseudogene, and querying it as a therapeutic target is likely due to a misidentification or misunderstanding of its annotation[7][1][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin B pseudogene 5 (UBBP5).